Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red cells and platelets. Modifications for special patients

C M Lehman1, J L Becker, D S Wilkinson

  • 1Intermountain Health Care Donor Services, LDS Hospital, Salt Lake City, Utah, USA.

Clinics in Laboratory Medicine
|December 1, 1996
PubMed
Summary

Leukoreduced blood components effectively prevent transfusion reactions. Their routine use for other clinical applications requires further experimental validation and cost-effectiveness evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglial interferon signaling and Aβ plaque pathology are enhanced in female 5xFAD Alzheimer's disease mice, independent of estrous cycle stage.

Journal of neuroinflammation·2025
Same author

4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism.

AJNR. American journal of neuroradiology·2020
Same author

Clinical Utility of a Novel Ultrafast T2-Weighted Sequence for Spine Imaging.

AJNR. American journal of neuroradiology·2018
Same author

Development and evaluation of real-time TaqMan® RT-PCR assays for the detection of avian nephritis virus and chicken astrovirus in chickens.

Avian pathology : journal of the W.V.P.A·2010
Same author

Nicotine and extinction of fear conditioning.

Neuroscience·2009
Same author

A seroprevalence investigation of chicken astrovirus infections.

Avian pathology : journal of the W.V.P.A·2009

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Blood component modification is essential for specific patient needs.
  • Technological advancements are narrowing indications for traditional blood components.
  • Leukoreduced blood components are increasingly considered for clinical use.

Purpose of the Study:

  • To review the clinical applications of leukoreduced blood components.
  • To evaluate the evidence supporting their use in preventing transfusion reactions.
  • To assess the experimental status and cost-effectiveness of other indications.

Main Methods:

  • Review of published data on leukoreduced blood components.
  • Analysis of clinical outcomes related to transfusion reactions.
  • Evaluation of current evidence for broader applications.

Related Experiment Videos

Main Results:

  • Published data support leukoreduced components for preventing febrile nonhemolytic transfusion reactions.
  • Evidence for other indications is currently limited and considered experimental.
  • Cost-effectiveness requires evaluation for experimentally validated uses.

Conclusions:

  • Leukoreduced blood components are proven for preventing febrile nonhemolytic transfusion reactions.
  • Wider adoption for other uses necessitates further research and economic analysis.
  • Current experimental use should be rigorously evaluated.